- Home
- BBIO vs GIB Comparison
BBIO vs GIB Comparison
Compare BBIO & GIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BBIO | GIB |
|---|---|---|
| Founded | 2015 | 1976 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.3B | 16.0B |
| IPO Year | 2019 | 1999 |
Fundamental Metrics
Financial Performance| Metric | BBIO | GIB |
|---|---|---|
| Price | $75.79 | $77.28 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 25 | 3 |
| Target Price | $86.04 | ★ $112.00 |
| AVG Volume (30 Days) | ★ 1.5M | 365.7K |
| Earning Date | 04-29-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.60% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $502,076,000.00 | N/A |
| Revenue This Year | $89.45 | $8.33 |
| Revenue Next Year | $73.78 | $2.96 |
| P/E Ratio | ★ N/A | $13.59 |
| Revenue Growth | ★ 126.26 | N/A |
| 52 Week Low | $31.77 | $69.40 |
| 52 Week High | $84.94 | $110.07 |
Technical Indicators
Market Signals| Indicator | BBIO | GIB |
|---|---|---|
| Relative Strength Index (RSI) | 56.95 | 61.88 |
| Support Level | $70.65 | $70.05 |
| Resistance Level | $78.20 | $93.65 |
| Average True Range (ATR) | 2.49 | 2.01 |
| MACD | 0.19 | 0.73 |
| Stochastic Oscillator | 60.99 | 82.39 |
Price Performance
Historical ComparisonAbout BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About GIB CGI Inc.
CGI is a Canada-based IT-services provider with an embedded position in North America and Europe. The company is one of the major IT suppliers to different levels of government around the world. It offers a broad portfolio of services such as consulting, systems integration, application maintenance, and business process services to governments and the private sector. With offices in over 40 countries, CGI follows a balanced global delivery model with most consultants in client proximity.